fibrinogen has been researched along with Myelodysplastic Syndromes in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Li, R; Shang, H; Zhao, L | 1 |
Aisa, Y; Akimoto, M; Fujita, Y; Ito, C; Nakazato, T; Ogura, S; Sakurai, A; Tanigawa, T; Yonei, S | 1 |
Aisa, Y; Akimoto, M; Ito, C; Nakazato, T; Nishiyama-Fujita, Y; Sakurai, A | 1 |
Chauffaille, Mde L; Kimura, EY; López, A; Matarraz, S; Oguro, T; Orfao, A; Quijano, S; Sandes, AF; Yamamoto, M | 1 |
Ezaki, K; Hasegawa, A; Hirano, M; Ino, T; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Okamoto, M; Tsuzuki, M | 1 |
Iijima, M; Otsuka, F; Watanabe, R | 1 |
Blanco, A; de Tezanos Pinto, M; Dupont, J; Fernández, J; Lazzari, M; Maugeri, N; Meschengieser, S | 1 |
7 other study(ies) available for fibrinogen and Myelodysplastic Syndromes
Article | Year |
---|---|
Acute Promyelocytic Leukemia Suggesting a Diagnosis of Myelodysplastic Syndrome: a Diagnostic Dilemma.
Topics: Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Myelodysplastic Syndromes; Peroxidase | 2022 |
Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fibrinogen; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Survival Rate | 2020 |
The prognostic value of the Fibrinogen-Albumin Ratio Index in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Prognosis; Proportional Hazards Models; Retrospective Studies; ROC Curve; Serum Albumin, Human | 2021 |
Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.
Topics: Aged; Aged, 80 and over; Antigens, CD; Biomarkers; Blood Platelets; Dual Specificity Phosphatase 2; Female; Fibrinogen; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunophenotyping; Male; Megakaryocytes; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Platelet Activation; Prognosis; Risk; Severity of Illness Index; Survival Rate; Thrombocytopenia | 2012 |
[Retrospective study of acute myelogenous leukemia in 83 elderly patients: clinical and biological characteristics].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Blood Proteins; Chromosome Deletion; Creatinine; Fibrinogen; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Peroxidase; Prognosis; Retrospective Studies; Translocation, Genetic | 2000 |
A case of neutrophilic dermatosis (ND) complicated by cryofibrinogenemia (CFGN) and myelodysplastic syndrome (MDS).
Topics: Cryoglobulins; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Middle Aged; Myelodysplastic Syndromes; Sweet Syndrome | 1992 |
Platelet function and intraplatelet von Willebrand factor antigen and fibrinogen in myelodysplastic syndromes.
Topics: Adenosine Diphosphate; Aged; Antigens; Bleeding Time; Blood Platelets; Cytoplasm; Epinephrine; Female; Fibrinogen; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Platelet Adhesiveness; Platelet Aggregation; Platelet Count; von Willebrand Factor | 1987 |